Table 3.

Main side effects of DA leading to discontinuation (several possible in the same subject)

	PPX-PR (N = 76)		ROP-XL (N = 165)		RTG (N = 183)
Age range	< 75 years (N = 52)	≥ 75 years (N = 24)	< 75 years (N = 117)	≥ 75 years (N = 48)	< 75 years (N = 122)	≥ 75 years (N = 61)
Skin reaction (%)	NA	NA	NA	NA	9.8	4.4
Lack of effect (%)	0	0	1.8	0	5.5	3.8
Somnolence (%)	0	1.3	1.2	0.6	0.5	0.5
Hallucinations (%)	1.3	2.6	2.4	1.8	1.1	1.1
Confusion (%)	0	1.3	1.2	0.6	0.5	1.6
ICD (%)	0	2.6	3.6	1.2	1.6	0.5

PPX-PR pramipexole prolonged release, ROP-XL ropinirole extended release, RTG rotigotine, ICD impulse control disorder, N number, DA dopamine agonists